Vitamin C for Sepsis

Dr. Alpha A. Fowler of Virginia Commonwealth University presented findings from the CITRIS-ALI trial that studied the role of vitamin C in patients with septic ARDS. The findings were presented @ESICM in Berlin and have just... read more

Effect of Vitamin C Infusion on Organ Failure in Patients With Sepsis and ARDS

In this preliminary study of patients with sepsis and Acute Respiratory Distress Syndrome (ARDS), a 96-hour infusion of vitamin C compared with placebo did not significantly improve organ dysfunction scores or alter markers... read more

Effect of Vitamin C Infusion on Organ Failure in Patients With Sepsis and ARDS

Comparison of Diagnostic Accuracy Among Procalcitonin, C-reactive protein, and Interleukin 6 for Blood Culture Positivity in General ICU Patients

Despite various technological advances, it still usually takes at least 24 to 48 h to obtain a blood culture result. The subsequent delays in diagnosis and treatment of infection can negatively impact care in the intensive... read more

Comparison of Diagnostic Accuracy Among Procalcitonin, C-reactive protein, and Interleukin 6 for Blood Culture Positivity in General ICU Patients

Derivation and Validation of Plasma Endostatin for Predicting Renal Recovery from AKI

Plasma endostatin shows a useful value for predicting failure to recover from acute kidney injury (AKI). The predictive ability can be greatly improved when endostatin is combined with the Sequential Organ Failure Assessment... read more

Derivation and Validation of Plasma Endostatin for Predicting Renal Recovery from AKI

Phenotyping: Need to Identify Subgroups of ARDS Patients

The consensus definitions of acute respiratory distress syndrome (ARDS) mainly rely on feasible clinical criteria, which help to group patients together for inclusion in clinical trials and for clinical management. This generates... read more

Phenotyping: Need to Identify Subgroups of ARDS Patients

Combined Biomarkers Predict Acute Mortality Among Critically Ill Patients With Suspected Sepsis

Combined biomarkers predict risk for 14-day and total mortality among subjects with suspected sepsis. Serum amyloid P and tissue plasminogen activator demonstrated the best discriminatory ability in this cohort. Fourteen-day... read more

Combined Biomarkers Predict Acute Mortality Among Critically Ill Patients With Suspected Sepsis

Immunotherapy Effects on Sepsis

A randomised controlled multicentre trial assessed for the first time the safety and pharmacokinetics of an antiprogrammed cell death-ligand 1 (anti–PD-L1) immune checkpoint inhibitor (BMS-936559; Bristol-Myers Squibb,... read more

Immunotherapy Effects on Sepsis

Neutrophil Extracellular Traps Are Elevated in Patients with Pneumonia-related ARDS

Bronchoalveolar neutrophil extracellular trap concentration was not significantly associated with mechanical ventilation duration in pneumonia-related ARDS. The acute respiratory distress syndrome (ARDS) is the most severe... read more

Neutrophil Extracellular Traps Are Elevated in Patients with Pneumonia-related ARDS

New Guidelines for Hospital-acquired Pneumonia/Ventilator-associated Pneumonia

American and European guidelines have many areas of common agreement such as limiting antibiotic duration. Both guidelines were in favor of a close clinical assessment. Neither recommended a regular use of biomarkers but... read more

New Guidelines for Hospital-acquired Pneumonia/Ventilator-associated Pneumonia

Surfactant protein D is a causal risk factor for COPD

Surfactant protein D (SP-D) is produced primarily in the lung and is involved in regulating pulmonary surfactants, lipid homeostasis and innate immunity. Circulating SP-D levels in blood are associated with chronic obstructive... read more

Surfactant protein D is a causal risk factor for COPD

The utility of biomarkers in traumatic brain injury clinical management

Currently, TBI management is guided by clinical histories and neuroimaging techniques. While these techniques may be advanced, they are more costly than serum analysis, involve exposure to ionizing radiations, and have certain... read more

The utility of biomarkers in traumatic brain injury clinical management

Metabolic-based Biomarkers Have Potential to Triage Children with Sepsis

A new study has validated potential biomarkers for a sepsis-triage model to distinguish sepsis patients requiring care in the pediatric intensive care unit (PICU) from sepsis identified in the pediatric emergency department... read more

Metabolic-based Biomarkers Have Potential to Triage Children with Sepsis

The impact of age on the innate immune response and outcomes after severe sepsis/septic shock in trauma and surgical ICU patients

Aged, critically ill surgical patients have greater organ dysfunction and incidence of adverse clinical outcomes after sepsis. Biomarker profiles suggest an immunophenotype of persistent immunosuppression and catabolism.... read more

The impact of age on the innate immune response and outcomes after severe sepsis/septic shock in trauma and surgical ICU patients

Blood test may obviate need for head CTs in brain trauma evaluation

A biomarker test based on the presence of two proteins in the blood appears to be suitable for ruling out significant intracranial injuries in patients with a history of mild traumatic brain injury (TBI) without the need... read more

Blood test may obviate need for head CTs in brain trauma evaluation

Early PREdiction of Sepsis Using Leukocyte Surface Biomarkers

From a large panel of leukocyte biomarkers, immunosuppression biomarkers were associated with subsequent sepsis in ED patients with suspected acute infection. Between January 2014 and February 2016, we recruited 272, 59 and... read more

Early PREdiction of Sepsis Using Leukocyte Surface Biomarkers

Viral Sepsis in Children

Sepsis in children is typically presumed to be bacterial in origin until proven otherwise, but frequently bacterial cultures ultimately return negative. Although the incidence of viral-induced sepsis is not precisely known,... read more

Circulating Biomarkers May be Unable to Detect Infection at the Early Phase of Sepsis in ICU Patients

During the study period, 363 patients with SIRS were screened, 84 having exclusion criteria. Ninety‑one patients were classified as having non‑septic SIRS and 188 as having sepsis. Eight biomarkers had an area under... read more

Circulating Biomarkers May be Unable to Detect Infection at the Early Phase of Sepsis in ICU Patients

Temporal Biomarker Profiles and Their Association with ICU Acquired Delirium

While there are differences in markers (adiponectin and several brain proteins) between patients with and without delirium, the development of delirium is not preceded by a change in the biomarker profile of inflammatory... read more

Temporal Biomarker Profiles and Their Association with ICU Acquired Delirium

Genomics and Pharmacogenomics of Sepsis: So Close and Yet So Far

Sapru et al. show in this issue of Critical Care that variants of thrombomodulin and the endothelial protein C receptor, but not protein C, are associated with mortality and organ dysfunction (ventilation-free and organ failure-free... read more

Genomics and Pharmacogenomics of Sepsis: So Close and Yet So Far

Biomarkers for Prediction of RRT in AKI

Acute kidney injury (AKI) frequently occurs in critically ill patients and often precipitates use of renal replacement therapy (RRT). However, the ideal circumstances for whether and when to start RRT remain unclear. We performed... read more

Biomarkers for Prediction of RRT in AKI

Evidence for Persistent Immune Suppression in Patients Who Develop Chronic Critical Illness After Sepsis

Many sepsis survivors develop chronic critical illness (CCI) and are assumed to be immunosuppressed, but there is limited clinical evidence to support this. We sought to determine whether the incidence of secondary infections... read more

Evidence for Persistent Immune Suppression in Patients Who Develop Chronic Critical Illness After Sepsis